Abstract We read with great interest the paper titled BX-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis^pub-lished by Wang et al in Tumor Biology, 2014, 35:411-418. Their results suggest that codon 399 polymorphism of XRCC1 gene might contribute to individual's susceptibility to lung cancer in Asian population and especially in nonsmoking Chinese women. The result is encouraging. Nevertheless, several key issues are worth noticing.
overlapped with the data reported by Su et al. [41] . As a consequence, 5986 cases and 6495 controls were calculated two times in Wang et al.'s paper [3] . In addition, two eligible papers [7, 23] published before 2013 was not included in Wang et al.'s paper [3] . Therefore, it is required to verify the conclusions by Wang et al. [3] . In order to clarify the association between XRCC1 Arg399Gln polymorphism and lung cancer risk, a meta-analysis including the updated data was reconducted, which may provide comprehensive evidence for this association. We also presented the stratified results by mainly confounding factors such as source of control, ethnicity, smoking status, histological subtypes, and Hardy-Weinberg equilibrium (HWE) in control besides giving overall estimates. A comprehensive search was performed through the database of Medline/PubMed, Science Direct, Elsevier, China National Knowledge Infrastructure (CNKI), and Wanfang Medical Online with a combination of the following terms: Blung cancer,^Blung neoplasm^or Blung carcinoma^and BXRCC1^or Brs25487^and Bpolymorphism^or Bvariant.L ast search was updated on March 20, 2015 . The references cited in the publications and review articles were also manually searched.
Data inclusion criteria were as follows: (a) the papers reporting lung cancer risk and XRCC1 codon 399 polymorphism; (b) case-control studies or cohort studies; and (c) sufficient data to estimate the OR and 95 % CI. For overlapping or repeated studies, the results including more information were included. Accordingly, papers lacking essential information were excluded; review papers were also excluded. In total, 69 published papers were identified with the association between XRCC1 Arg399Gln polymorphism and lung cancer risk. We reviewed all papers in the light of the criteria defined above and excluded 12 reviews and 9 overlapping articles. Therefore, 48 studies were determined to enter our study.
The Cochrane Q statistics test was used to assess the heterogeneity among studies. A fixed-effects model or a random-effects model was applied to estimate the combined effects according to the results of heterogeneity test [62] . A fixed-effects model is used while the effects are assumed to be homogenous; otherwise, a randomeffects model is used. The funnel plot was drawn to evaluate publication bias visually. In addition, Begg's test and Egger's test were used to assess the publication bias [63, 64] . The χ 2 test was used to check whether the genotype frequencies of the controls were in agreement with HWE. All of the statistical analyses were conducted by using Review Manager (version 4.2.10, the Cochrane Collaboration) and STATA10.0 software package (Stata Corporation, College Station, TX). Statistical significance was determined as a two-sided P value less than 0.05 for any test or model. Table 1 lists the characteristics of included studies. Table 2 lists the summary effects of the association cancer risk, and the summary ORs were 0.98 (95 % CI 0.92-1.05) for CM vs. CC (Fig. 2 ) and 1.02 (95 % CI 0.95-1.10) for CM+MM vs. CC (Fig. 3) , respectively. Our results are consistent with Wang et al.'s study [3] .
They also found that the MM genotype was associated with increased risk of lung cancer compared with CC genotype in total population. Limiting the analysis to studies of control in agreement with HWE, we did not (Table 2) , which is consistent with Wang et al.'s results [3] . When stratified by source of control, we observed an increased lung cancer risk among subjects carrying MM genotype compared with those carrying CC genotype on the basis of hospitalbased control (OR=1.37, 95 % CI 1.11-1.70); we did not observe the association of XRCC1 codon 399 polymorphism with lung cancer risk on the basis of population-based control (Table 2) . We did not observe the association between XRCC1 codon 399 polymorphism and lung cancer risk in additional subgroup analyses by smoking status and histological subtypes ( Table 2) . The shape of funnel plots did not reveal any evidence of obvious asymmetry (Figs. 4, 5 , and 6) among total studies, which suggested that there was not any potential publication bias. Begg's test and Egger's test suggested that there was no obvious publication bias in this study, except for the analysis under the genetic model of CM vs. MM among Caucasians, since the P value was less than 0.05 in Egger's test (Table 2) .
In summary, our results suggest that XRCC1 codon 399 MM genotype variant was associated with an increased lung cancer risk, especially among Asians. To reach a definitive conclusion, further well-designed studies with large sample size are needed to verify the association of XRCC1 codon 399 polymorphism and lung cancer risk. We hope that this remark will contribute to a more accurate elaboration and substantiation of the results presented by Wang et al. [3] . 
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